In Partnership with ATC Genomics, the Company Presented One of Asia’s Largest Real-World Datasets (n=12,281) for AI-Powered Multi-Cancer Early Detection…
Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, targeting…